Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Malignant tumors represent a significant global health challenge, ranking as the second leading cause of death worldwide.
• Current cancer treatment heavily relies on anti-tumor drugs, necessitating advancements in therapeutic strategies.
• Emerging research highlights cell signal transduction pathway dysregulation as a key driver of cancer cell proliferation.

Purpose of the Study:

• To review current anti-tumor drug targets in cancer therapy.
• To analyze the molecular mechanisms underlying the efficacy of novel anti-cancer agents.
• To provide a foundation for future research and development in targeted cancer treatments.

Main Methods:

• Literature review of anti-tumor drug targets.
• Analysis of molecular mechanisms of action for targeted therapies.
• Synthesis of information on signaling pathway abnormalities in cancer.

Main Results:

• Identification of key signaling pathways dysregulated in tumor cells.
• Summary of novel anti-tumor drugs targeting these specific pathways.
• Understanding the shift from cytotoxic to targeted anti-cancer drug development.

Conclusions:

• Targeted anti-cancer drugs offer a new generation of therapies focused on specific molecular abnormalities.
• Understanding molecular mechanisms is crucial for effective drug development and cancer treatment.
• The review provides a basis for advancing targeted therapies and combating rising cancer mortality.